Every function in the body relies on the lungs to receive and deliver oxygen. The lungs contain tiny air sacs called alveoli, which release carbon dioxide and absorb oxygen. In pulmonary fibrosis, lung tissue (alveoli) becomes thickened and scarred, compromising the lungs’ ability to perform its necessary function. The thickened tissue is unable to deliver oxygen to the bloodstream, and the otherwise simple task of breathing becomes laborious and difficult.
There are several culprits and causative agents in pulmonary fibrosis. Chemicals or toxins may cause pulmonary fibrosis, for example: the inhalation of asbestos, silica and pesticides. Cigarette smoking, other diseases and infections, drugs, radiation and genetics may all be contributing factors in the progression of pulmonary fibrosis, as well. Pulmonary fibrosis may also stem from unknown causes, and in these cases, is referred to as idiopathic pulmonary fibrosis. The condition always begins with chronic inflammation that damages the fragile lung alveoli. When this tissue is damaged, the body’s natural response is to cover it with scar tissue.
The symptoms of pulmonary fibrosis often directly influence the quality of life for patients. Trouble breathing, fatigue, dry cough and chest pain often interfere with daily activities. More serious symptoms like weight loss can put the patient at increased risk. Weight loss is commonly seen in the progressed stages of pulmonary fibrosis, as labored breathing burns several calories and takes large amounts of energy.
There is currently no cure for pulmonary fibrosis. Treatment is based on preventing progression and improving quality of life. Immune suppressants are commonly prescribed to reduce inflammation and prevent further scarring. Supplemental oxygen therapy is used to reduce breathlessness, while more severe treatment options include lung transplantation. Unfortunately, many of these treatments interfere with other body systems and are accompanied with major risks and side effects, forcing the patient to choose between their disease and other ailments.
Systemic enzyme therapy is a promising route for those with pulmonary fibrosis. As an all-natural alternative, systemic enzymes offer anti-inflammatory properties without adverse side effects. When taken on an empty stomach, enzymes enter the blood stream and break down the components of scar tissue. Since enzymes have a property called specificity, they don’t harm healthy tissues, which is important when addressing critical organs like the lungs.
Aside from addressing existing scar tissue, enzymes also work within the blood to scavenge and digest the particles that later become fibrin, which is the main component in scar tissue. Prolonged use of systemic enzymes for both preventative measures and therapeutic routes is an applicable option for those suffering with pulmonary fibrosis.
Whether you have been diagnosed with pulmonary fibrosis or have a family member or friend with the disorder, this blog is designed to provide you with real stories from real people who have found relief from their pulmonary fibrosis symptoms using systemic enzyme therapy. The blog is meant to offer hope to those looking for a natural alternative therapy that actually works, and to provide information on alternative therapies for inflammatory disease.